These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22569604)

  • 21. Nesiritide and Me.
    Kittleson MM
    Circ Heart Fail; 2018 Aug; 11(8):e005440. PubMed ID: 30354567
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of nesiritide in patients with acute decompensated heart failure.
    O'Connor CM; Starling RC; Hernandez AF; Armstrong PW; Dickstein K; Hasselblad V; Heizer GM; Komajda M; Massie BM; McMurray JJ; Nieminen MS; Reist CJ; Rouleau JL; Swedberg K; Adams KF; Anker SD; Atar D; Battler A; Botero R; Bohidar NR; Butler J; Clausell N; Corbalán R; Costanzo MR; Dahlstrom U; Deckelbaum LI; Diaz R; Dunlap ME; Ezekowitz JA; Feldman D; Felker GM; Fonarow GC; Gennevois D; Gottlieb SS; Hill JA; Hollander JE; Howlett JG; Hudson MP; Kociol RD; Krum H; Laucevicius A; Levy WC; Méndez GF; Metra M; Mittal S; Oh BH; Pereira NL; Ponikowski P; Tang WH; Tanomsup S; Teerlink JR; Triposkiadis F; Troughton RW; Voors AA; Whellan DJ; Zannad F; Califf RM
    N Engl J Med; 2011 Jul; 365(1):32-43. PubMed ID: 21732835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with nesiritide at a community hospital.
    Olin JL; Chan A
    Am J Health Syst Pharm; 2004 Jul; 61(13):1337-8. PubMed ID: 15287225
    [No Abstract]   [Full Text] [Related]  

  • 25. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nesiritide, heart failure, and renal dysfunction: irrational exuberance or throwing the baby out with the bathwater. Editorial to: "Impact of nesiritide on renal function and mortality in patients suffering from heart failure" by Dontas et al.
    Witteles RM
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):183-6. PubMed ID: 19353257
    [No Abstract]   [Full Text] [Related]  

  • 27. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.
    Hiestand B; Abraham WT
    Curr Cardiol Rep; 2007 May; 9(3):182-6. PubMed ID: 17470330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nesiritide speeds recovery time for heart failure patients.
    Morrow T
    Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
    Silver MA
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S28-36. PubMed ID: 15627916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG; Redfield MM; Burnett JC; Chen HH
    J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract]   [Full Text] [Related]  

  • 34. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Dunavant S
    JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux.
    Pleister AP; Baliga RR; Haas GJ
    Curr Heart Fail Rep; 2011 Sep; 8(3):226-32. PubMed ID: 21695395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is nesiritide really that good or that bad?
    Cheng TO
    Am Heart J; 2006 Apr; 151(4):e1; author reply e3. PubMed ID: 16569525
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of death with nesiritide.
    Burger AJ
    JAMA; 2005 Aug; 294(8):897; author reply 898. PubMed ID: 16118377
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there a use for nesiritide in pediatric patients?
    Schamberger MS
    J Intensive Care Med; 2004; 19(3):171-3. PubMed ID: 15154998
    [No Abstract]   [Full Text] [Related]  

  • 39. Nesiritide in acute heart failure.
    Burger AJ; Silver MA
    Lancet; 2003 Sep; 362(9388):998; author reply 998-9. PubMed ID: 14511939
    [No Abstract]   [Full Text] [Related]  

  • 40. Nesiritide use in pediatric patients with congestive heart failure.
    Feingold B; Law YM
    J Heart Lung Transplant; 2004 Dec; 23(12):1455-9. PubMed ID: 15607680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.